Newsletter | March 24, 2025

03.24.25 -- Rapid Pharmacology Data Generation For Your Global Registration Trials

 

 

A Fast and Reliable Turnkey Solution

Whether springboarding your first-in-human study, generating data that informs your global registration trials, completing required Phase I studies for your NDA submission or post-marketing commitment fulfillment, Altasciences is poised and ready to accelerate your clinical pharmacology needs with our turnkey solutions.

 

With a deep understanding of the challenges and nuances in drug development, Altasciences is committed to providing solutions that safely accelerate timelines, improve outcomes, and ensure regulatory compliance. Discover the difference through the insightful resources below.

Streamlining Clinical Trial Start-Up For Accelerated Drug Development

Find out how open dialogue, aligned expectations, and direct communication with the sponsor contributed to a clinical trial start-up of only 3.5 weeks.

 

Strategic Site Identification: A Proven Approach

Discover how Altasciences' unique site-selection process ensures a strong feasibility plan and rapid study initiation.

 

Intrinsic And Extrinsic Factors Altering Drug Exposure And Toxicity

Explore the important role of drug interaction studies in minimizing adverse effects and optimizing treatment response.

 

Assessing Human Abuse Potential To Curb Prescription Drug Misuse

Learn how the FDA has undertaken efforts to manage the misuse and abuse of prescription drugs, including opioid analgesics, through guidelines for understanding the abuse potential of new drugs.

 

Shortening Drug Development Timelines With Asian Ethnobridging Trials

Discover how ethnobridging studies streamline the approval process in Asian markets and address potential disparities in drug metabolism between Asian and non-Asian populations.

 

SOLUTIONS

Renal And Hepatic Impaired Studies

Find out more about how Altasciences has successfully designed, conducted, analyzed, and reported on numerous clinical trials focused on renal and hepatic impairment across a wide range of therapeutic areas. 

• Request Information

 

 

 

Clinical Pharmacology Studies For NDA Filing

See why Altasciences is the CRO/CDMO partner you can trust to help you navigate the NDA submission process.

• Request Information